FDA warns Platinum Strategies
This article was originally published in The Tan Sheet
Executive Summary
FDA warns Platinum Strategies that several of its weight-loss products marketed as dietary supplements are unapproved prescription drugs because they include sibutramine - the active pharmaceutical ingredient in the obesity drug Meridia. In a Sept. 23 warning letter, FDA listsPineapple Fat Reducing Slimming Capsule, Tomato Slimming and other products as unapproved new prescription drugs. The agency also notes the firm's Web site has offered other products that contain sibutramine, including Starcaps. Several NFL players alleged Starcaps, made by Balanced Health Products, contained undeclared bumetanide, a diuretic banned by the league (1"The Tan Sheet" Dec. 1, 2008)
You may also be interested in...
GSK's Quick Warning Of Fake Alli Exemplifies Effective Crisis Management
GlaxoSmithKline's quick response to consumer complaints about counterfeit alli for sale on Internet auction sites exemplifies effective crisis management and could even boost the OTC weight-loss brand's reputation, an expert says
Diuretic found in StarCaps
Balanced Health Products voluntarily recalls one lot of the weight-loss supplement, which contained the undeclared diuretic bumetanide, FDA says Nov. 24. Bumetanide can cause serious loss of fluids and electrolytes and elevated uric acid concentrations. The New York City-based firm's president, Nikki Haskell, suspended shipment of StarCaps after National Football League players alleged the product was tainted after they were suspended for testing positive for bumetanide, which may mask steroid use (1"The Tan Sheet" Nov. 3, 2008, In Brief)
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.